Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus
Open accessThe DOI matches its Crossref record; 43 of the 45 references it cites were found in a registry or an index.
Abstract
The restriction of viral receptors and coreceptors to the basolateral surface of airway epithelial cells has been blamed for the inefficient transfer of viral vectors to the apical surface of this tissue. We now report, however, that differentiated human airway epithelia internalize rAAV type-2 virus efficiently from their apical surfaces, despite the absence of known adeno-associated virus-2 (AAV-2) receptors or coreceptors at these sites. The dramatically lower transduction efficiency of rAAV infection from the apical surface of airway cells appears to result instead from differences in endosomal processing and nuclear trafficking of apically or basolaterally internalized virions. AAV capsid proteins are ubiquitinated after endocytosis, and gene transfer can be significantly enhanced by proteasome or ubiquitin ligase inhibitors. Tripeptide proteasome inhibitors increased persistent rAAV gene delivery from the apical surface >200-fold, to a level nearly equivalent to that achieved with basolateral infection. In vivo application of proteasome inhibitor in mouse lung augmented rAAV gene transfer from undetectable levels to a mean of 10.4 +/- 1.6% of the epithelial cells in large bronchioles. Proteasome inhibitors also increased rAAV-2-mediated gene transfer to the liver tenfold, but they did not affect transduction of skeletal or cardiac muscle. These findings suggest that tissue-specific ubiquitination of viral capsid proteins interferes with rAAV-2 transduction and provides new approaches to circumvent this barrier for gene therapy of diseases such as cystic fibrosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In vitro and preclinical animal studies have shown administration of bortezomib prevents degradation of internalized AAVs, reduces capsid presentation, and increases transduction efficiency by enhancing nuclear translocation of AAV [165, 224, 225].”
From Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer (2023) · cites this paper as [224]
In the citing paper
“After entry into cells, AAV cells can be ubiquitinated for degradation in proteasomes (91), generating increased amount of antigens for immune activation.”
From A versatile toolkit for overcoming AAV immunity (2022) · cites this paper as [91]
In the citing paper
“AAV capsids undergo proteosome-mediated degradation in the cytoplasm, which may expose the packaged genomes to cytoplasmic DNA sensors.”
From Innate immune sensing of adeno-associated virus vectors (2024) · cites this paper as [43]
Citations
Cites
Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., & Goldberg, A. L. (1994) · Cell · doi:10.1016/s0092-8674(94)90462-6 · Cited by 2,524 · cited 1×
“Several specific, cellpermeable, peptide aldehyde inhibitors of proteasome pathways have recently been discovered (30, 31).”
BackgroundFenteany, G., Standaert, R. F., Lane, W. S., Choi, S., Corey, E. J., & Schreiber, S. L. (1995) · Science · doi:10.1126/science.7732382 · Cited by 1,583 · cited 1×
“Several specific, cellpermeable, peptide aldehyde inhibitors of proteasome pathways have recently been discovered (30, 31).”
BackgroundSummerford, C., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1438-1445.1998 · Cited by 1,406 · cited 1×
“Recently, the heparin sulfate proteoglycan receptor (3), and FGFR-1 (4) and αVβ5 integrin (5) coreceptors for AAV-2, have been localized to the basolateral membrane of polarized airway epithelial cells (6, 7).”
BackgroundMultiple proteolytic systems, including the proteasome, contribute to CFTR processing
Jensen, T. J., Loo, M. A., Pind, S., Williams, D. B., Goldberg, A. L., & Riordan, J. R. (1995) · Cell · doi:10.1016/0092-8674(95)90241-4 · Cited by 897 · cited 18×
“A similar result was achieved when another ubiquitinproteasome pathway inhibitor, Z-LLL (33), was tested (data not shown).”
BackgroundInfluentialαVβ5 integrin: a co-receptor for adeno-associated virus type 2 infection
Summerford, C., Bartlett, J. S., & Samulski, R. J. (1999) · Nature Medicine · doi:10.1038/4768 · Cited by 711
Fisher, K. J., Gao, G. P., Weitzman, M. D., DeMatteo, R., Burda, J. F., & Wilson, J. M. (1996) · Journal of Virology · doi:10.1128/jvi.70.1.520-532.1996 · Cited by 547 · cited 2×
“Alternative approaches have attempted to increase transgene expression by enhancing the molecular conversion of nonfunctional viral genomes to expressible forms, as in the case of rAAV (12, 13), or by increasing transcription and translation efficiency by altering the transgene expression cassettes (14).”
BackgroundDuan, D., Sharma, P., Yang, J., Yue, Y., Dudus, L., Zhang, Y., Fisher, K. J., & Engelhardt, J. F. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8568-8577.1998 · Cited by 522 · cited 2×
“It has been previously shown that AAV transduction in certain tissues such as muscle and retina is very efficient (16, 38), whereas other tissues including lung and liver are less favorably transduced (6, 39).”
BackgroundMethodSelf-citationThe Ubiquitin-Proteasome Pathway and Pathogenesis of Human Diseases
Schwartz, P., & Ciechanover, M. (1999) · Annual Review of Medicine · doi:10.1146/annurev.med.50.1.57 · Cited by 466 · cited 2×
“Regulated intracellular proteolysis through proteasomes plays a critical role in many physiological and pathological conditions (35).”
BackgroundSamulski, R. J., Chang, L. S., & Shenk, T. (1987) · Journal of Virology · doi:10.1128/jvi.61.10.3096-3101.1987 · Cited by 449 · cited 1×
“The entire β-galactosidase expression cassette, including the RSV promoter, β-galactosidase reporter gene, and SV40 polyA signal, was excised by Sal I digestion and subsequently cloned into the pSub201 backbone by blunt-end ligation (18).”
MethodHuman fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2
Qing, K., Mah, C., Hansen, J., Zhou, S., Dwarki, V., & Srivastava, A. (1999) · Nature Medicine · doi:10.1038/4758 · Cited by 443
Research works printed but not linked: 3
- Zabner, 1996, Gene Ther, 3, 458
- Hughes, 1993, Lab Invest, 69, 173
- Bennett, 1997, Invest Ophthalmol Vis Sci, 38, 2857
Cited by
Items 201–300 of 389
Novel Therapies for the Treatment of Cystic Fibrosis: New Developments in Gene and Stem Cell Therapy
Sueblinvong, V., Suratt, B. T., & Weiss, D. J. (2007) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2007.02.004 · Cited by 34
Quantitative real-time PCR for titration of infectious recombinant AAV-2 particles
Rohr, U., Heyd, F., Neukirchen, J., Wulf, M.-A., Queitsch, I., Kroner‐Lux, G., Steidl, U. G., Fenk, R. R., Haas, R. R., & Kronenwett, R. (2005) · Journal of Virological Methods · doi:10.1016/j.jviromet.2005.03.006 · Cited by 36
The SUMOylation Pathway Restricts Gene Transduction by Adeno-Associated Viruses
Hölscher, C., Sonntag, F., Henrich, K., Chen, Q., Beneke, J., Matula, P., Rohr, K., Kaderali, L., Beil, N., Erfle, H., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005281 · Cited by 36
“Suppression of either function leads to increased transduction and it has been shown that AAV is a direct target of these post-translational modifications [35 – 38].”
Viral Vectors, Animal Models, and Cellular Targets for Gene Therapy of Cystic Fibrosis Lung Disease
Tang, Y., Yan, Z., & Engelhardt, J. F. (2020) · Human Gene Therapy · doi:10.1089/hum.2020.013 · Cited by 37
Self-citationAdeno-associated Virus and AAV Vectors for Gene Delivery
Carter, B. J., Burstein, H., & Peluso, R. W. (2000) · CRC Press eBooks · doi:10.1201/9781420002126-12 · Cited by 34
Quantitative 3D Tracing of Gene-delivery Viral Vectors in Human Cells and Animal Tissues
Xiao, P.-J., Li, C., Neumann, A., & Samulski, R. J. (2012) · Molecular Therapy · doi:10.1038/mt.2011.250 · Cited by 33
Yan, Z., Lei-Butters, D. C. M., Keiser, N. W., & Engelhardt, J. F. (2012) · Gene Therapy · doi:10.1038/gt.2012.46 · Cited by 34
Self-citationLiu, X., Luo, M., Trygg, C., Yan, Z., Lei-Butters, D. C. M., Smith, C. I., Fischer, A. C., Munson, K. B., Guggino, W. B., Bunnell, B. A., et al. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300277 · Cited by 34
Self-citationA role for adeno-associated viral vectors in gene therapy
Coura, R., & Nardi, N. B. (2008) · Genetics and Molecular Biology · doi:10.1590/s1415-47572008000100001 · Cited by 37
“In general, the tropism is associated with abundance of the specific receptor/coreceptor, but there are exceptions (Duan et al., 1999; Duan et al., 2000), suggesting that probably there are other internalization pathways independent of known receptors (Ding et al., 2005).”
BackgroundCelastrol enhances AAV1-mediated gene expression in mice adipose tissues
Zhang, F., Jia, S.-Q., Zheng, S.-P., & Ding, W. (2010) · Gene Therapy · doi:10.1038/gt.2010.120 · Cited by 31
Liver-Directed Adeno-Associated Viral Gene Therapy for Hemophilia
Markusic, D. M., & Herzog, R. W. (2013) · Journal of Genetic Syndromes & Gene Therapy · doi:10.4172/2157-7412.s1-009 · Cited by 36
“AAV2 viral particle intracellular trafficking and uncoating also impact efficient gene transfer [21,22].”
BackgroundWhite, A. F., Mazur, M., Sorscher, E. J., Zinn, K. R., & Ponnazhagan, S. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.117 · Cited by 32
“Studies have demonstrated that by combining permeability-enhancing compounds with the use of transduction-enhancing compounds, gene transfer through the apical surface of human airway epithelium could be augmented (Duan et al., 2000; Ding et al., 2003).”
BackgroundWhole Body Skeletal Muscle Transduction in Neonatal Dogs with AAV-9
Yue, Y., Shin, J.-H., & Duan, D. (2011) · Methods in Molecular Biology · doi:10.1007/978-1-61737-982-6_21 · Cited by 29
“In this vector, AP gene expression is under the transcription regulation of the ubiquitous Rous sarcoma virus promoter (RSV) and the SV40 polyadenylation signal (see Note 1) (11).”
BackgroundSelf-citationDickey, D. D., Excoffon, K. J. D. A., Koerber, J. T., Bergen, J., Steines, B. R., Klesney‐Tait, J., Schaffer, D. V., & Zabner, J. (2011) · Journal of Virology · doi:10.1128/jvi.05154-11 · Cited by 32
“Others have suggested that different steps in the AAV life cycle are rate-limiting steps, including endosomal escape and intracellular trafficking (7, 35).”
BackgroundNakai, H., Fuess, S., Storm, T. A., Meuse, L. A., & Kay, M. A. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(02)00034-5 · Cited by 29
Fakhiri, J., & Grimm, D. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.04.005 · Cited by 30
Chemical Modulation of Endocytic Sorting Augments Adeno-associated Viral Transduction
Berry, G. E., & Asokan, A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.687657 · Cited by 29
“Most studies to date have focused on proteasome inhibitors such as MG132 (20), Llnl (21), and bortezomib or carfilzomib (22, 23), which have been shown to increase AAV transduction through increased nuclear/nucleolar accumulation of viral particles.”
BackgroundDevelopment of rAAV2-CFTR: History of the First rAAV Vector Product to be Used in Humans
Loring, H. S., ElMallah, M. K., & Flotte, T. R. (2016) · Human Gene Therapy Methods · doi:10.1089/hgtb.2015.150 · Cited by 33
“Instead, the marked low expression of apically internalized virions stems from differences in the endosomal processing and nuclear trafficking compared with virions internalized basolaterally.(49) Because the barrier to effective transgene expression is at the level of endosomal processing and ubiquination, modulation…”
BackgroundResultInfluentialDíaz‐Lezama, N., Wu, Z., Adán‐Castro, E., Arnold, E., Vázquez‐Membrillo, M., Zamarripa, D. A., Ledesma-Colunga, M. G., Moreno-Carranza, B., de la Escalera, G. M., Colosi, P., et al. (2015) · Laboratory Investigation · doi:10.1038/labinvest.2015.135 · Cited by 29
Improving clinical efficacy of adeno associated vectors by rational capsid bioengineering
Sen, D. (2014) · Journal of Biomedical Science · doi:10.1186/s12929-014-0103-1 · Cited by 32
“The ubiquitin–proteasome pathway has been shown to play an essential role in AAV intracellular trafficking [26,27] and this pathway has been shown to be modulated by epidermal growth factor receptor protein tyrosine kinase (EGFR-PTK) signaling [28].”
Guggino, W. B., Benson, J. M., Seagrave, J., Yan, Z., Engelhardt, J. F., Gao, G., Conlon, T. J., & Cebotaru, L. (2017) · Human Gene Therapy Clinical Development · doi:10.1089/humc.2017.067 · Cited by 28
“When AAV2 is endocytosed across the apical membrane, the viral particles are ubiquitinated and ultimately degraded in proteasomes and therefore do not reach the nucleus, where transduction normally occurs.(40) This limitation, among others, led to the hunt for new and more efficient viral vectors (both natural and syn…”
BackgroundSelf-citationPolarized AAVR expression determines infectivity by AAV gene therapy vectors
Hamilton, B. A., Li, X., Pezzulo, A. A., Alaiwa, M. H. A., & Zabner, J. (2019) · Gene Therapy · doi:10.1038/s41434-019-0078-3 · Cited by 29
Directed evolution of adeno-associated virus 5 capsid enables specific liver tropism
Wang, Y., Yang, C., Hu, H., Chen, C., Yan, M., Ling, F., Wang, K. C., Wang, X., Deng, Z., Zhou, X., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.03.017 · Cited by 27
“Proteasome inhibition facilitates AAV2- and AAV5-mediated gene transfer in hepatocytes and airway epithelial cells, but not cardiac or skeletal muscles.(50,58,59) Site-directed mutagenesis of potentially ubiquitinated lysine residues on the AAV2 capsid protein surface ameliorates liver transduction in vivo.”
BackgroundBAAV Transcytosis Requires an Interaction with β-1-4 Linked- Glucosamine and gp96
Di Pasquale, G., Kaludov, N., Agbandje-McKenna, M., & Chiorini, J. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009336 · Cited by 25
“While some interactions will lead to entry and infection of the cells, others will lead to the destruction of the virus in the cytosol [1–3].”
BackgroundGranio, O., Excoffon, K. J. D. A., Henning, P., Melin‐Heschel, P., Norez, C., Gonzalez, G., Karp, P. H., Magnusson, M. K., Habib, N., Lindholm, L., et al. (2009) · Human Gene Therapy · doi:10.1089/hum.2009.056 · Cited by 26
“Indeed, several viruses have distinct traffick-ing pathways when infected from the apical surface in comparison with the basolateral surface (Duan et al. , 2000; Jia et al. , 2006; Vermeer et al. , 2007; Excoffon et al. , 2008).”
Gonçalves, M. A. F. V., van der Velde, I., Janssen, J. M., Maassen, B., Heemskerk, E., Opstelten, D.-J. E., Knaän‐Shanzer, S., Valerio, D., & de Vries, A. A. F. (2002) · Journal of Virology · doi:10.1128/jvi.76.21.10734-10744.2002 · Cited by 29
“Other limitations of AAV-based vectors include their relatively slow nuclear import (2, 17), a high dependence on particular milieus for efficient intracellular trafficking (6, 23, 33), and, once in the nucleus, the requirement to convert the single-stranded DNA genomes into transcriptionally competent double-stranded…”
BackgroundDual Vector Expansion of the Recombinant AAV Packaging Capacity
Duan, D., Yue, Y., & Engelhardt, J. F. (2003) · Cardiac Cell and Gene Transfer · doi:10.1385/1-59259-350-x:29 · Cited by 26
Self-citationChaanine, A. H., Nonnenmacher, M., Kohlbrenner, E., Jin, D., Kovacic, J. C., Akar, F. G., Hajjar, R. J., & Weber, T. (2014) · Gene Therapy · doi:10.1038/gt.2014.7 · Cited by 25
Copreni, E., Castellani, S., Palmieri, L., Penzo, M., & Conese, M. (2008) · The Journal of Gene Medicine · doi:10.1002/jgm.1248 · Cited by 25
“microscopy in the present and previous studies [5,36].”
ResultKeswani, S. G., Balaji, S., Le, L. D., Leung, A., Katz, A. B., Lim, F. Y., Habli, M. A., Jones, H. N., Wilson, J. M., & Crombleholme, T. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043633 · Cited by 25
“Significant progress is being made to achieve high-efficiency transduction of airway epithelium, including using chemicals and a combination of transduction-enhancing compounds after vector transduction [45–47], shortened AAV cassette [48], intramolecular joining of DNA or RNA from independent vectors [49–51], genetic…”
Viral Membrane Fusion Proteins and RNA Sorting Mechanisms for the Molecular Delivery by Exosomes
Zubarev, I. V., Vladimirtsev, D., Vorontsova, M. V., Blatov, I., Shevchenko, K. G., Zvereva, S. D., Lunev, E. A., Файзулоев, Е. Б., & Barlev, N. (2021) · Cells · doi:10.3390/cells10113043 · Cited by 24
“However, the capsid proteins may trigger intracellular and extracellular antiviral responses [3].”
BackgroundAdeno-associated virus serotype-9 efficiently transduces the retinal outer plexiform layer.
Lei, B., Zhang, K., Yue, Y., Ghosh, A., & Duan, D. (2009) · PubMed Central · Cited by 27
Self-citationGene Therapy for Cystic Fibrosis Airway Disease- Is Clinical Success Imminent?
Anson, D. S., Smith, G., & Parsons, D. (2006) · Current Gene Therapy · doi:10.2174/156652306776359496 · Cited by 29
AAV8 virions hijack serum proteins to increase hepatocyte binding for transduction enhancement
Pei, X., He, T., Hall, N. E., Gerber, D., Samulski, R. J., & Li, C. (2018) · Virology · doi:10.1016/j.virol.2018.02.007 · Cited by 23
Adeno-Associated Virus: The Naturally Occurring Virus Versus the Recombinant Vector
Srivastava, A. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.29017.asr · Cited by 24
Next Generation of Adeno-Associated Virus Vectors for Gene Therapy for Human Liver Diseases
Berns, K. I., & Srivastava, A. (2019) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2019.02.005 · Cited by 23
The proteasome metabolizes peptide-mediated nonviral gene delivery systems
Kim, J., Chen, C.-P., & Rice, K. G. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302575 · Cited by 23
Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins
Auricchio, A., O’Connor, E., Weiner, D. E., Gao, G., Hildinger, M., Wang, L., Calcedo, R., & Wilson, J. M. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215780 · Cited by 24
Gene Therapy for Airway Diseases
Pilewski, J. M. (2002) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.27.2.f244 · Cited by 23
“Unlike adenovirus, there also appear to be inefficiencies related to processing of adeno-associated virus in the endocytic pathway, as inhibition of ubiquitination or proteosome function significantly increases gene transfer efficiency to mouse airway with AAV 2 (46).”
BackgroundGene Therapy for Cystic Fibrosis: Lessons Learned and Paths Forward
Choi, S. H., & Engelhardt, J. F. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.01.010 · Cited by 22
Self-citationKaminsky, P., Keiser, N. W., Yan, Z., Lei-Butters, D. C. M., & Engelhardt, J. F. (2012) · Molecular Therapy · doi:10.1038/mt.2011.295 · Cited by 24
Self-citationJang, J.-H., Koerber, J. T., Gujraty, K. V., Bethi, S. R., Kane, R. S., & Schaffer, D. V. (2010) · Gene Therapy · doi:10.1038/gt.2010.81 · Cited by 22
AAV-6 mediated efficient transduction of mouse lower airways
Li, W., Zhang, L., Wu, Z., Pickles, R. J., & Samulski, R. J. (2011) · Virology · doi:10.1016/j.virol.2011.06.009 · Cited by 22
“…has a unique ability at escaping the ubiquitin/proteasome degradation pathway in mouse airway epithelia The ubiquitin/proteasome pathway plays a role in AAV transduction of non-polarized cell lines and differentiated human airway epithelia (Douar et al., 2001; Duan et al., 2000; Yan et al., 2004).”
BackgroundMethodAdeno-associated Virus and Lentivirus Pseudotypes for Lung-directed Gene Therapy
Wilson, J. M. (2004) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200409-041ms · Cited by 22
“Although some level of gene transfer is indeed detected in animal models, it is quite low ( 24 ).”
BackgroundInput Virion Proteins: Cryptic Targets of Antivector Immune Responses in Preimmunized Subjects
Lowenstein, P. R. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.05.019 · Cited by 23
Tang, Y., Yan, Z., Lin, S., Huntemann, E. D., Feng, Z., Park, S.-Y., Sun, X., Yuen, E., & Engelhardt, J. F. (2020) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2020.09.008 · Cited by 21
“Importantly, these events that limit transduction can be overcome by transient application of proteasome inhibitors during or after the transduction period.(11,12,15,18)”
BackgroundSelf-citationTang, S., Sambanis, A., & Sibley, E. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.245 · Cited by 23
Restoring Ciliary Function: Gene Therapeutics for Primary Ciliary Dyskinesia
Keiser, N. W., Cant, E., Sitaraman, S., Shoemark, A., & Limberis, M. (2023) · Human Gene Therapy · doi:10.1089/hum.2023.102 · Cited by 20
Development of Multiple Cloning Site cis -Vectors for Recombinant Adeno-Associated Virus Production
Yue, Y., & Duan, D. (2002) · BioTechniques · doi:10.2144/02333dd03 · Cited by 20
Self-citationLiu, S., Chowdhury, E. A., Xu, V., Jerez, A., Mahmood, L., Ly, B. Q., Le, H. K., Nguyen, A., Rajwade, A., Meno‐Tetang, G. M. L., et al. (2023) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2023.10.005 · Cited by 19
Rodríguez, E. G., Romero, C., Río, A., Miralles, M., Raventós, A., Planells‐Ferrer, L., Burgueño, J. F., Hamada, H., Perales, J. C., Bosch, A., et al. (2013) · Human Gene Therapy Methods · doi:10.1089/hgtb.2012.096 · Cited by 18
“In fact, polarized epithelial cells are more permissive to basolateral than to apical transduction, suggesting different vector binding and trafficking pathways between the apical and the basolateral membranes (Duan et al., 2000; Esclatine et al., 2001; Tang et al., 2005).”
Yan, Z., Sun, X., Evans, I. A., Tyler, S. R., Song, Y., Liu, X., Sui, H., & Engelhardt, J. F. (2013) · Human Gene Therapy · doi:10.1089/hum.2013.137 · Cited by 18
“786 an air–liquid interface (ALI) led to the finding that postentry barriers are primarily responsible for low efficiency of rAAV2 transduction from the apical surface (Duan et al., 2000).”
BackgroundSelf-citationDeleterious effect of peptide insertions in a permissive site of the AAV2 capsid
Douar, A. M., Poulard, K., & Danos, O. (2003) · Virology · doi:10.1016/s0042-6822(03)00186-7 · Cited by 17
Retina transduction by rAAV2 after intravitreal injection: Comparison between mouse and rat
Dias, M. S., Araujo, V. G., Vasconcelos, T., Li, Q., Hauswirth, W. W., Linden, R., & Petrs-Silva, H. (2019) · Gene Therapy · doi:10.1038/s41434-019-0100-9 · Cited by 17
Zhang, J., Frabutt, D. A., Chrzanowski, M., Li, N., Miller, L. M., Tian, J., Mulcrone, P. L., Lam, A. K., Draper, B. E., Jarrold, M. F., et al. (2024) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2024.101206 · Cited by 17
“3 However, it is crucial to note that scAAV vector preparations may still contain particles with monomeric DNA, and the proportion of such particles varies depending on the size of the packaged genome.”
BackgroundNovel approaches to augment adeno-associated virus type-2 endocytosis and transduction
Şanlioğlu, A. D., Karaçay, B., Benson, P. K., Engelhardt, J. F., & Şanlıoğlu, S. (2004) · Virus Research · doi:10.1016/j.virusres.2004.03.002 · Cited by 17
“…and Samulski, 1998) and co-receptors (Qing et al., 1999; Summerford et al., 1999) at the cell surface, ubiquitination of endocytosed virus (Duan et al., 2000), nuclear trafficking (Hansen et al., 2000), and gene conversion to duplex expressible forms (Alexander et al., 1994; Ferrari et…”
BackgroundSelf-citationMaddalena, A., Dell'Aquila, F., Giovannelli, P., Tiberi, P., Wanderlingh, L. G., Montefusco, S., Tornabene, P., Iodice, C., Visconte, F., Carissimo, A., et al. (2018) · Human Gene Therapy · doi:10.1089/hum.2017.220 · Cited by 16
“…the following were evaluated: AAV2 capsid interaction with a 5 b 1 integrin, which is an AAV co-receptor in HEK293 cells 46 ; AAV2 capsid phosphorylation, which has been described to target AAV particles to proteasome degradation 29 ; and ATM activation, which favors AAV genome circularization.”
InfluentialBraun‐Falco, M., Eisenried, A., B�ning, H., & Ring, J. (2005) · Archives of Dermatological Research · doi:10.1007/s00403-005-0547-y · Cited by 20
“MG132 at 4 lM for 24 h, that has been shown to lead to a 200-fold enhancement of gene expression in primary human bronchial cells [16], was toxic to keratinocytes.”
BackgroundChng, K., Larsen, S. R., Zhou, S., Wright, J. F., Martiniello‐Wilks, R., & Rasko, J. E. J. (2006) · The Journal of Gene Medicine · doi:10.1002/jgm.990 · Cited by 16
Gene therapy of cystic fibrosis (CF) airways: A review emphasizing targeting with lactose
Klink, D. T., Glick, M. C., & Scanlin, T. F. (2001) · Glycoconjugate Journal · doi:10.1023/a:1020879524587 · Cited by 16
“Moreover, transfection with AAV from the apical membrane may also be limited by endosomal processing [ 25 ].”
BackgroundExcoffon, K. J. D. A., Lin, S., Narayan, P. K. L., Sitaraman, S., Jimah, A. M., Fallon, T. T., James, M. L., Glatfelter, M. R., Limberis, M. P., Smith, M. D., et al. (2024) · Human Gene Therapy · doi:10.1089/hum.2024.063 · Cited by 16
“14,15 In contrast to VCN, the average amount of hCFTR D R mRNA (copies per l g total RNA) demonstrated a direct relationship with both SP-101 MOI and doxorubicin HCl concentrations (Fig.”
Lei, B., Zhang, K., Yue, Y., Ghosh, A., & Duan, D. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-1399-9_77 · Cited by 16
Self-citationFakhiri, J., Landegger, L. D., & Grimm, D. (2020) · Hearing Research · doi:10.1016/j.heares.2020.108092 · Cited by 15
Gilkes, J. A., Judkins, B. L., Herrera, B. N., Mandel, R. J., Boye, S. L., Boye, S. L., Srivastava, A., & Heldermon, C. D. (2020) · Gene Therapy · doi:10.1038/s41434-020-00206-w · Cited by 15
Insights gained in the pathology of lung disease through single‐cell transcriptomics
Carraro, G., & Stripp, B. R. (2022) · The Journal of Pathology · doi:10.1002/path.5971 · Cited by 17
“An improved understanding of mechanisms governing viral trafficking in lung epithelial cells [47], together with the availability of animal models in which the CF phenotype more closely resemble CF lung disease in patients, will aid in the development of more effective delivery Figure 1.”
BackgroundDirectional entry and release of Zika virus from polarized epithelial cells
Tamhankar, M. A., & Patterson, J. L. (2019) · Virology Journal · doi:10.1186/s12985-019-1200-2 · Cited by 15
Bockstael, O., Melas, C., Pythoud, C., Levivier, M., McCarty, D. M., Samulski, R. J., Witte, O. D., & Tenenbaum, L. (2012) · Human Gene Therapy · doi:10.1089/hum.2011.216 · Cited by 15
“This delay was suggested to reflect limiting steps such as viral particle intracellular trafficking (Duan et al., 2000), uncoating of the virion (Thomas et al.”
Keiser, N. W., & Engelhardt, J. F. (2013) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg1309s78 · Cited by 14
“For example, polarity of the airway epithelial cells results in significant sidedness (i.e., apical versus basolateral) in gene-transfer efficiency (Duan et al., 1998b, 2000; Yan et al., 2006, 2012).”
InfluentialSelf-citationShi, W., Hemminki, A., & Bartlett, J. S. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.06.020 · Cited by 15
“, proteosomal degradation or altered intracellular trafficking), could be limiting AAV2 transduction [27,28,46].”
BackgroundZhang, Y., Chen, Z., Wang, X., Yan, R., Bao, H., Chu, X., Guo, L., Wang, X., Li, Y., Mu, Y., et al. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.07.023 · Cited by 13
Excoffon, K. J. D. A., Smith, M. D., Falese, L., Schulingkamp, R. J., Lin, S., Mahankali, M., Narayan, P., Glatfelter, M. R., Limberis, M. P., Yuen, E., et al. (2024) · Human Gene Therapy · doi:10.1089/hum.2024.064 · Cited by 14
Naumer, M., Popa-Wagner, R., & Kleinschmidt, J. A. (2012) · Journal of General Virology · doi:10.1099/vir.0.044735-0 · Cited by 14
“Before it travels to the nucleus, AAV exits from the endosomal compartment and is prone to ubiquitin-dependent proteasomal degradation (Duan et al., 2000; Yan et al., 2002; Zhong et al., 2008).”
BackgroundLim, F. Y., Martin, B. G., Sena‐Esteves, M., Radu, A. P., & Crombleholme, T. M. (2002) · Journal of Pediatric Surgery · doi:10.1053/jpsu.2002.33843 · Cited by 13
Adeno-associated virus for cystic fibrosis gene therapy
Martini, S. V., Rocco, P. R. M., & Morales, M. M. (2011) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2011007500123 · Cited by 14
“The use of these factors has been shown to increase the expression of the reporter transgene about 1000 times (76).”
BackgroundNovel Lung Tropic Adeno-Associated Virus Capsids for Therapeutic Gene Delivery
Carneiro, A. D., Lee, H., Lin, L. W., van Haasteren, J., & Schaffer, D. V. (2020) · Human Gene Therapy · doi:10.1089/hum.2020.169 · Cited by 13
“57,58 In addition, a study described in greater detail below suggested endosomal escape as a key limitation in viral transduction.”
Binny, C., & Nathwani, A. C. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-873-3_6 · Cited by 12
Vidović, D., Gijsbers, R., Quiles‐Jiménez, A., Dooley, J., den Haute, C. V., der Perren, A. V., Liston, A., Baekelandt, V., Debyser, Z., & Carlon, M. S. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.109 · Cited by 12
“29,30 The mouse nasal mucosa reflects the human lung closely based on cell composition and bioelec-tric properties.”
Tang, Y., Fakhari, S., Huntemann, E. D., Feng, Z., Wu, P., Feng, W. Y., Lei, J., Yuan, F., Excoffon, K. J. D. A., Wang, K., et al. (2023) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2023.02.015 · Cited by 13
“proteasome-dependent post-entry block in transport of the virus to the nucleus.(12,13) Second, the small vector package capacity of rAAV necessitated the use of the weak intrinsic promoter activity of the inverted terminal repeat (ITR) sequence for expression of the fulllength CFTR cDNA.”
BackgroundSelf-citationOrthopaedic gene therapy using recombinant adeno-associated virus vectors
Ke, J., Zheng, L. W., & Cheung, L. K. (2011) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2010.12.010 · Cited by 14
Vector serotype screening for use in ovine perinatal lung gene therapy
McClain, L. E., Davey, M. G., Zoltick, P. W., Limberis, M. P., Flake, A. W., & Peranteau, W. H. (2016) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2016.02.048 · Cited by 12
“Also, reagents that help AAV vectors bypass the natural resistance of the apical surface to infection can augment AAV transduction 10- to 100-fold [18] [19] Similarly dosage, proliferation rates, and target cell access are factors involved in efficient transduction by AAV vectors in lung epithelia [20].”
BackgroundAdeno-associated virus vector-mediated gene delivery to the vasculature and kidney.
Kapturczak, M., Chen, S., & Agarwal, A. (2005) · Acta Biochimica Polonica · doi:10.18388/abp.2005_3442 · Cited by 13
“the limited transduction efficiency of rAAV2 vectors (Duan et al., 2000; Nicklin et al., 2001).”
Aktaş, Z., Rao, H., Slauson, S. R., Gabelt, B. T., Larsen, I. V., Sheridan, R. T. C., Herrnberger, L., Tamm, E. R., Kaufman, P. L., & Brandt, C. R. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-22074 · Cited by 12
Role of Essential Metal Ions in AAV Vector-Mediated Transduction
Rambhai, H. K., Ashby, F. J., Qing, K., & Srivastava, A. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.05.019 · Cited by 11
Novel vectors forin vivogene delivery to vascular tissue
White, K., Nicklin, S. A., & Baker, A. H. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.6.809 · Cited by 12
“It may be due to sequestration of the virus in the extracellular matrix by binding to HSPG [103] and/or proteasomal degradation of the virus while it is trafficking to the nucleus [102,105,106] .”
BackgroundProspects for gene therapy in lung disease
Davies, J. C. (2001) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00048-0 · Cited by 11
Fu, Y., Sibley, E., & Tang, S. (2008) · Journal of General Virology · doi:10.1099/vir.0.2008/001446-0 · Cited by 10
“Transduction barriers have been identified at different stages of rAAV2–host cell interaction; these stages include internalization, endocytosis, ubiquitination–proteasome pathway, uncoating and second-strand DNA synthesis (Tang et al., 2005; Duan et al., 2000; Thomas et al., 2004; Ferrari et al., 1996).”
BackgroundLopes‐Pacheco, M., Kitoko, J. Z., Morales, M. M., Petrs‐Silva, H., & Rocco, P. R. M. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.09.015 · Cited by 11
Boyle, M., Enke, R. A., Reynolds, J. B., Mogayzel, P. J., Guggino, W. B., & Zeitlin, P. L. (2006) · Virology Journal · doi:10.1186/1743-422x-3-29 · Cited by 15
“In particular, the lack of surface HSPG on the apical membrane of respiratory epithelial cells has been identified as a serious obstacle to effective gene therapy [21,22].”
BackgroundComplement yourself: transcomplementation rescues partially folded mutant proteins
Cebotaru, L., & Guggino, W. B. (2014) · Biophysical Reviews · doi:10.1007/s12551-014-0137-3 · Cited by 11
“It has been suggested that one reason that AAV2-based vectors transduce inefficiently is the lack of viral receptors on the apical surface (Duan et al. 2000).”
BackgroundInfluentialChimeric AAV Cap sequences alter gene transduction
Ward, P., & Walsh, C. (2009) · Virology · doi:10.1016/j.virol.2009.01.012 · Cited by 11
“This serotype-dependent variance in AAV transduction is probably a function of both cellular entry and of capsid-dependent post-entry effects (Douar et al., 2001; Duan et al., 2000; Hauck et al., 2004; Wang et al., 2007).”
BackgroundReactive oxygen species enhance rAAV transduction by promoting its escape from late endosomes
Huang, X., Wang, X. Q., Ren, Y., Gao, P., Xu, W., Xie, X., & Diao, Y. (2023) · Virology Journal · doi:10.1186/s12985-023-01964-w · Cited by 9
“Cytoplasmic fraction and nuclear fraction) were analyzed to determine the purity of each fraction as described previously [18, 19].”
Comparative Efficacy of Intratracheal Adeno-Associated Virus Administration to Newborn Rats
Fleurence, E., Rivière, C., Lacaze‐Masmonteil, T., Franco‐Montoya, M., Waszak, P., Bourbon, J. R., Danos, O., Douar, A. M., & Delacourt, C. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.1298 · Cited by 9
“Inefficient viral entry (Teramoto et al ., 1998; Bals et al ., 1999), associated with limited endosomal processing and viral particle degradation (Duan et al ., 2000), was shown to hinder rAAV2-mediated gene transfer to airway epithelium.”
A Novel Class of Intrinsic Proteasome Inhibitory Gene Transfer Peptides
Martin, M. E., & Rice, K. G. (2007) · Bioconjugate Chemistry · doi:10.1021/bc700362b · Cited by 8
“Co-administration of tripeptide proteasome inhibitors increased gene expression from the apical surface by over 200-fold in cell culture and also increased AAV-mediated gene transfer in the liver and lung (9).”
BackgroundInfluentialShort-Term Steroid Treatment of Rhesus Macaque Increases Transduction
Yanda, M. K., Tomar, V., Cebotaru, C. V., Guggino, W. B., & Cebotaru, L. (2021) · Human Gene Therapy · doi:10.1089/hum.2021.239 · Cited by 8
“53,54 On the contrary, Liu et al. have 52 shown that AAV1 is highly efficient in transducing ferret airway epithelial cells grown as polarized monolayers and shows less sensitivity to proteasome inhibitors than does AAV2, suggesting that both the presence of apical receptors and apical entry…”
Development of Targeted Viral Vectors for Cardiovascular Gene Therapy
Nicklin, S. A., & Baker, A. H. (2003) · Springer eBooks · doi:10.1007/978-1-4615-0073-5_2 · Cited by 9
Yanda, M. K., Zeidan, A., Ciobanu, C., Izzi, J. M., Guggino, W. B., & Cebotaru, L. (2023) · Human Gene Therapy · doi:10.1089/hum.2023.095 · Cited by 7
“Duan et al. 22 have made the surprising discovery that inefficient gene transfer of AAV2 via the airways is not caused by a lack of uptake of the virus, as originally thought, but rather occurs through the degradation of virus internalized via the apical membrane.”
Recent strategies for enhanced delivery of mRNA to the lungs
Heiser, B. J., Veyssi, A., & Ghosh, D. (2025) · Nanomedicine · doi:10.1080/17435889.2025.2485669 · Cited by 8
Management of Pulmonary Disease in Patients with Cystic Fibrosis
Robinson, C. A., & Kuhn, R. J. (2001) · Journal of Pharmacy Practice · doi:10.1106/4wvw-acld-ekv6-mbjj · Cited by 7
Ning, K., Zhang, X. J., Feng, Z., Hao, S., Küz, Ç. A., Cheng, F., Park, S. Y., McFarlin, S., Engelhardt, J. F., Yan, Z., et al. (2023) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2023.101115 · Cited by 8
Self-citationBaker, A. H. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00072-8 · Cited by 9
“Since AAV-2-mediated transduction can also be negatively impacted by intracellular mechanisms such as proteasome degradation”
Background
Metadata
- Authors
- Duan, D., Yue, Y., Yan, Z., Yang, J., & Engelhardt, J. F.
- Affiliations
- University of Iowa (US)
- Corresponding author
- Engelhardt, John F.
- Venue
- Journal of Clinical Investigation
- Published
- 2000-06-01
- Volume
- 105
- Issue
- 11
- Pages
- 1573-1587
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC300848
- OpenAlex
- W1970138286
- Cited by
- 391
- References
- 45
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 10 · 2023: 12 · 2022: 8 · 2021: 5 · 2020: 9 · 2019: 17 · 2018: 6 · 2017: 9 · 2016: 4 · 2015: 11 · 2014: 10 · 2013: 18 · 2012: 18
- FWCI
- 13.93
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (DK54759)
- National Heart, Lung, and Blood Institute (R01HL058340)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK54759, P30DK054759)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Keywords
- adeno-associated virus type 2, airway epithelium, endosomal processing, proteasome inhibitors, ubiquitin ligase inhibitors, nuclear trafficking, pulmonary gene therapy, cystic fibrosis
- MeSH terms
- Dependovirus, Animals, Bronchi, Capsid, Cells, Cultured, Cysteine Endopeptidases, Egtazic Acid, Epithelial Cells, Humans, Lung, Mice, Inbred BALB C, Multienzyme Complexes, Endosomes, Ubiquitins, Genetic Therapy, Cell Polarity, Gene Transfer Techniques, Proteasome Endopeptidase Complex, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.